Adcendo ApS ("Adcendo"), a biotech company focused on the development of first and best-in-class antibody-drug conjugates ...
A shareholder class action lawsuit has been filed against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX). The lawsuit alleges that Defendants made ...
A 60-year-old woman has been charged with animal cruelty after an investigation was conducted by the Vinton Police Department ...
Each year, six Nobel Prizes are awarded in the fields of physiology or medicine, physics, chemistry, economics, literature ...
3don MSN
9 Major Medicare Changes for 2026: What's Coming for Premiums, Drug Prices, and Program Cuts
Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news ...
Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...
The Show was live at Crescent Ballroom for an evening of conversations, music and stories. And no one tells a better story ...
How far can your NBA squad go this season? What if everything falls apart? Here are the best- and worst-case scenarios for ...
AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...
News-Medical.Net on MSN
Scalable synthetic biology revolutionizes targeted therapy with logic-gate proteins
Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results